Search Results - "Ruckser, R."

S179: RANDOMIZED COMPARISON BETWEEN KRD AND KTD INDUCTION, FOLLOWED BY K MAINTENANCE OR OBSERVATION IN TRANSPLANT NON‐ELIGIBLE PATIENTS WITH NDMM (AGMT‐MM02 TRIAL) by Ludwig, H., Melchardt, T., Sormann, S., Zojer, N., Andel, J., Hartmann, B., Tinchon, C., Gunsilius, E., Podar, K., Egle, A., Willenbacher, W., Wöll, E., Schreder, M., Ruckser, R., Bozic, B, Krauth, M.‐T., Petzer, A., Schmitt, C, Machherndl‐Spandl, S., Agis, H., Fillitz, M., Pönisch, W., Knop, S., Paiva, B., Greil, R.

Get full text

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial by Pirker, Robert, Prof, Pereira, Jose R, MD, Szczesna, Aleksandra, MD, von Pawel, Joachim, MD, Krzakowski, Maciej, Prof, Ramlau, Rodryg, MD, Vynnychenko, Ihor, MD, Park, Keunchil, Prof, Yu, Chih-Teng, MD, Ganul, Valentyn, Prof, Roh, Jae-Kyung, Prof, Bajetta, Emilio, Prof, O'Byrne, Kenneth, Prof, de Marinis, Filippo, MD, Eberhardt, Wilfried, MD, Goddemeier, Thomas, Dipl Stat, Emig, Michael, MD, Gatzemeier, Ulrich, MD

“…Summary Background Use of cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor (EGFR), has the potential to increase survival in…”
Get full text

347 (PB-142) - Real-World multicenter Austrian analysis of the safety and effectiveness of nab-paclitaxel in young and elderly patients with metastatic breast cancer by Steger, G., Petru, E., Haslbauer, F., Marth, C., Egle, D., Galid, A., Sliwa, T., Lang, A., Kuehr, T., Petzer, A., Ruckser, R., Greil, R., Mlineritsch, B., Singer, C., Seifert, M., Andel, J., Kwasny, W., Pichler, P., Tinchon, C., Bartsch, R.

Get full text

Real-World multicenter Austrian analysis of the safety and effectiveness of nab-paclitaxel in young and elderly patients with metastatic breast cancer by Steger, G., Petru, E., Haslbauer, F., Marth, C., Egle, D., Galid, A., Sliwa, T., Lang, A., Kuehr, T., Petzer, A., Ruckser, R., Greil, R., Mlineritsch, B., Singer, C., Seifert, M., Andel, J., Kwasny, W., Pichler, P., Tinchon, C., Bartsch, R.

Get full text

Serum levels of soluble CD44 variant isoforms are elevated in rheumatoid arthritis by KITTL, E. M, HABERHAUER, G, RUCKSER, R, SELLENY, S, RECH-WEICHSELBRAUN, I, HINTERBERGER, W, BAUER, K

“…Serum levels of soluble CD44 variant proteins including sequences encoded by exon v5 and exon v6 (sCD44v5, sCD44v6) were determined in patients with…”
Get full text

Safety and effectiveness of nab-paclitaxel in young and elderly patients with metastatic breast cancer: a prospective, multicenter non-interventional study by Steger, G., Petru, E., Haslbauer, F., Egle, D., Galid, A., Sliwa, T., Lang, A., Kühr, T., Petzer, A., Ruckser, R., Mlineritsch, B., Greil, R., Seifert, M., Singer, C., Andel, J., Kwasny, W., Marth, C., Pichler, P., Tinchon, C., Bartsch, R.

Get full text

PS1470 EFFICACY AND SAFETY OF ANAGRELIDE IN OLDER PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA by Buxhofer‐Ausch, V., Steurer, M., Sormann, S., Forjan, E., Schimetta, W., Gisslinger, B., Heibl, S., Krauth, M.‐T., Thiele, J., Ruckser, R., Gastl, G., Gisslinger, H.

“…Background: Anagrelide is licensed in Austria for first line treatment of patients with high risk essential thrombocythemia (ET). A recently published, large…”
Get full text

Treatment of lymphangioleiomyomatosis by ovariectomy, interferon alpha 2b and tamoxifen--a case report by Klein, M, Krieger, O, Ruckser, R, Rosen, A, Waldner, R, Preis, P, Beck, A

“…The gender-specific prevalence of lymphangioleiomyomatosis (LAM) in premenopausal women suggests a hormonal etiology. Despite the antiestrogenic treatment…”
Get full text

Relationship between the detection rate of EpCAM-positive circulating tumor cells (CTCs) in metastatic breast cancer patients and the CTC enrichment technology by Königsberg, R., Pfeiler, G., Obermayr, E., Gneist, M., Ruckser, R., Hudec, M., Zeillinger, R., Dittrich, C.

“…Abstract only…”
Get full text

Prolactin: a possible mediator of graft-versus-host disease following allogeneic bone marrow transplantation in humans by Hinterberger-Fischer, M, Kier, P, Spona, J, Sebesta, C, Tiefengraber, E, Habertheuer, K H, Ruckser, R, Schmid, A, Kalhs, P, Lechner, K

“…We have evaluated post-transplant serum levels of prolactin with respect to source of donated bone marrow (BM) and to the occurrence of either acute and/or…”
Get more information

ERCP and balloon dilation is a valuable alternative to surgical biliodigestive anastomosis in the long common channel syndrome in childhood by Sebesta, C, Schmid, A, Kier, P, Ruckser, R, Tiefengraber, E, Rosen, H, Stelzhammer, K, Geissler, K, Hruby, W, Horcher, E P

Get more information

A rare case of interstitial pneumonitis after tandem high‐dose melphalan conditioning and autologous stem cell transplantation in multiple myeloma by Buxhofer‐Ausch, Veronika, Ruckser, Reinhard, Kier, Peter, Habertheuer, Karl Heinz, Zelenka, Peter, Tatzreiter, Georg, Ausch, Christoph, Schmid, Isabel, Hruby, Walter, Reiner‐Concin, Angelika, Sebesta, Christian, Ogris, Emil, Hinterberger‐Fischer, Margareta, Hinterberger, Wolfgang

“…:  A 57‐yr‐old woman with multiple myeloma received an autologous tandem transplant at a 4‐month interval. She was conditioned twice with 225 mg/m2 melphalan…”
Get full text

Successful treatment of invasive mould infection affecting lung and brain in an adult suffering from acute leukaemia by Buxhofer, Veronika, Ruckser, Reinhard, Kier, Peter, Habertheuer, Karl‐Heinz, Tatzreiter, Georg, Zelenka, Peter, Dorner, Stefan, Sebesta, Christian, Knosp, Engelbert, Hruby, Walter, Hinterberger, Wolfgang

“…: We describe in detail a 67‐yr‐old woman who was treated with a cytostatic combination chemotherapy for newly diagnosed common‐acute lymphoblastic leukaemia…”
Get full text

Elevation of plasma prolactin in patients undergoing autologous blood stem-cell transplantation for breast cancer: Is its modulation a step toward posttransplant immunotherapy? by HINTERBERGER-FISCHER, M, OGRIS, E, SEBESTA, C, HINTERBERGER, W, KIER, P, BAUER, K, KITTL, E, HABERTHEUER, K.-H, RUCKSER, R, SCHMID, A, SELLENY, S, FANGL, M

“…Prolactin is a suspected promotor of breast cancer cell growth, and it shares pleiotropic immunoregulatory properties. We studied plasma prolactin and its…”
Get full text

Significance of minimal residual disease for the estimation of the prognosis and for therapeutic decisions in solid tumors by Hinterberger, W, Buxhofer, Veronika, Ogris, E, Zelenka, P, Kier, P, Ruckser, R, Dorner, S, Habertheuer, K H, Vedovelli, H, Schindler, S, Hinterberger-Fischer, M

“…The detection of disseminated tumor cells in bone marrow and blood is increasingly used for staging and therapeutic decisions in breast cancer and other solid…”
Get more information

Possible role of autotransplantation in small cel bronchial carcinoma by Tiefengraber, E, Sebesta, C, Kier, P, Ruckser, R, Habertheuer, K H, Hinterberger, W

“…Autologous bone marrow transplantation (ABMT) performed with recent achievements plays yet no established role in the treatment of small cell lung cancer…”
Get more information

Autologous bone marrow transplantation in intestinal carcinoma by Sebesta, C, Tiefengraber, E, Kier, P, Ruckser, R, Habertheuer, K H, Schmid, A, Hinterberger, W

“…Although adjuvant chemotherapy has made some progress in the treatment of colorectal cancer, chemotherapy of metastatic disease remains disappointing…”
Get more information

Evaluation of soluble CD44 splice variant v5 in the diagnosis and follow-up in breast cancer patients by Kittl, E M, Ruckser, R, Selleny, S, Samek, V, Hofmann, J, Huber, K, Reiner, A, Ogris, E, Hinterberger, W, Bauer, K

“…Aberrant expression of CD44 splice variants has been detected on a variety of human tumor cells. Overexpression of specific isoforms has been shown to be…”
Get more information

Clinical significance of autologous transplantation with hematopoietic stem cells in leukemia and solid tumors by Hinterberger, W, Adler, V, Bauer, K, Haberhauer, G, Habertheuer, K H, Höniger, S, Huber, K, Kier, P, Kittel, E, Ruckser, R

“…Autologous Transplantation of hematopoietic tissue with frozen hematopoietic stem cells is increasingly used for leukemias and lymphomas, but also for some…”
Get more information

Tandem transplantation with peripheral autologous hematopoietic blood stem cells in treatment of oncologic and hematologic malignancies. Initial results of the Donauspital, Vienna by Ruckser, R, Kier, P, Sebesta, C, Kittl, E, Kurz, M, Selleny, S, Höniger, S, Scherz, M, Habertheuer, K H, Zelenka, P

“…10 patients were subjected to tandem transplantation for breast cancer (n = 3), ovarian cancer (n = 2) and multiple myeloma (n = 5), at the Second Department…”
Get more information